Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRON-PH: Ferric Carboxymaltose in Pulmonary Hypertension
NCT07359599Phase 4Recruiting
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Jan 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), pulmonary hypertension (PH), sponsored by Ziekenhuis Oost-Limburg. Started Jan 2026; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07359599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07359599.